Sign up UNITED KINGDOM
Proactive Investors - Run By Investors For Investors

ITM Power sees strong growth in new orders and tender pipeline in financial year

The AIM-listed hydrogen energy company said in a trading update that its overall deal pipeline stood at £39mln, an increase of around 42% since June 2017
Hydrogen fuel
The group's tender opportunity pipeline had grown to over £250mln from £200mln in January

ITM Power plc (LON:ITM) saw strong growth in its orders and tender opportunity pipelines in the latest financial year.

The AIM-listed hydrogen energy company said in a trading update that its overall deal pipeline stood at £39mln, an increase of around 42% since June 2017 after recognising £10.4mln as income in the period.

READ: ITM Power CFO to join board as finance director

The group added that its tender opportunity pipeline had grown to over £250mln from £200mln in January and was spread across the three sectors of fuel, power to gas, and renewable energy.

In more general trading, the group said it expected total income for the latest financial year to be around £14mln, with a cash loss of around £5mln due to higher than expected costs following several one-off actors such as recruitment costs, higher factory testing costs, and first-of-a-kind plant equipment delivered.

ITM maintained that it still had a strong balance sheet with a year-end cash position of around £22mln and a positive working capital position of around £8mln.

The group will release its final results for the year ended 30 April 2018 in late July.

View full ITM profile View Profile

ITM Power plc Timeline

Related Articles

Hydrogen refuelling
April 05 2018
As the move towards alternative fuels for vehicles gathers pace, news last month of the opening of the first 'under the canopy' hydrogen refuelling station at Beaconsfield Services on the M40 deserved a bit of a fanfare
Dementia ward
January 15 2018
It's not exactly what the Silicon Valley companies would call a "pivot"; it's more of an acknowledgement that lighting solutions have to make full use of the available technology
Medical Scan
November 20 2017
The CE mark will enable Feedback to market not just to scientists, but radiologists everywhere, which should lead to a marked expansion in sales

No investment advice

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person. You further understand that none of the information providers or their affiliates will advise you personally concerning the nature, potential, advisability, value or suitability of any particular security, portfolio of securities, transaction, investment strategy, or other matter.

You understand that the Site may contain opinions from time to time with regard to securities mentioned in other products, including company related products, and that those opinions may be different from those obtained by using another product related to the Company. You understand and agree that contributors may write about securities in which they or their firms have a position, and that they may trade such securities for their own account. In cases where the position is held at the time of publication and such position is known to the Company, appropriate disclosure is made. However, you understand and agree that at the time of any transaction that you make, one or more contributors may have a position in the securities written about. You understand that price and other data is supplied by sources believed to be reliable, that the calculations herein are made using such data, and that neither such data nor such calculations are guaranteed by these sources, the Company, the information providers or any other person or entity, and may not be complete or accurate.

From time to time, reference may be made in our marketing materials to prior articles and opinions we have published. These references may be selective, may reference only a portion of an article or recommendation, and are likely not to be current. As markets change continuously, previously published information and data may not be current and should not be relied upon.

© Proactive Investors 2018

Proactive Investors Limited, trading as “Proactiveinvestors United Kingdom”, is Authorised and regulated by the Financial Conduct Authority.
Registered in England with Company Registration number 05639690. Group VAT registration number 872070825 FCA Registration number 559082. You can contact us here.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use